COVID-19 Effectiveness Study in the Philippines

Recruiting

• Conditions: Vaccine Effectiveness Against COVID-19; COVID-19; Hospitalized COVID-19

• Registration Number: NCT05518760
• Lead Sponsor: University of the Philippines

Brief Summary

This is a multi-site, observational, prospective test negative design case-control study which primarily aims to determine the protective effectiveness of 2 doses of an inactivated COVID-19 vaccine at least 14 days after the second dose, against hospitalized virologically-confirmed SARS-CoV-2 infection.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-08-25
• Study First Submitted QC: 2022-08-25
• Study First Posted: 2022-08-29
• Study Start: 2022-11-09
• Status Verified: 2022-12
• Last Update Submitted: 2022-12-01
• Last Update Posted: 2022-12-02
• Primary Completion: 2023-11-08
• Study Completion: 2024-03-15

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

• Written informed consent.
• Aged 18 years of age and above
• Residing in the catchment area of the participating hospital
• Admitted to the participating hospital with an acute respiratory illness
• Able and willing to provide a naso- and oro-pharyngeal swab for RT-PCR testing

Exclusion Criteria

• 6.2.2.1 Refusal to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of hospitalized virologically-confirmed SARS-CoV-2 infection	1 year

Trial Locations

Locations (1)

Vicente Sotto Memorial Medical Center; 🇵🇭 Cebu City, Cebu Province, Philippines